XSPI: Inside The Boosted Option Book Going Into Q4

Impact · against what's priced in

The article provides a neutral-to-negative outlook on XSPI, characterizing it as a tool for sideways markets with amplified downside risk. The modest total return advantage over peers like SPYI and GPIX suggests limited alpha despite aggressive options strategies.

XSPI−0.10: No priced-in read yet
In context: The fund's boosted exposure increases downside risk and sacrifices upside during rallies, resulting in total returns that only modestly outpace peers.
Read from the article alone

XSPI: Inside The Boosted Option Book Going Into Q4

dividends▲26%
etf
covered calls
income investing
options strategy
sp500
volatility

Top 1 mover · tap to explore

XSPI: Inside The Boosted Option Book Going Into Q4

How each ticker is affected

Connected tickers

Seeking to Outpace the S&P 500? Give Dividends a Shot

XSPI: Inside The Boosted Option Book Going Into Q4

How each ticker is affected

Connected tickers

Seeking to Outpace the S&P 500? Give Dividends a Shot

Track these names every morning.

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?

Cooking Up An Average Of 10% Yield From These Two CEFs

NNN REIT: A 6% Yield For Long-Term Investors

Bitcoin ETFs Just Had Their Biggest Outflow Day Since June. Is the Selling Over?

XSPI: Inside The Boosted Option Book Going Into Q4

How each ticker is affected

Connected tickers

Next reads from the same story arc

Seeking to Outpace the S&P 500? Give Dividends a Shot

XSPI: Inside The Boosted Option Book Going Into Q4

How each ticker is affected

Connected tickers

Next reads from the same story arc

Seeking to Outpace the S&P 500? Give Dividends a Shot

Track these names every morning.

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?

Cooking Up An Average Of 10% Yield From These Two CEFs

NNN REIT: A 6% Yield For Long-Term Investors

Bitcoin ETFs Just Had Their Biggest Outflow Day Since June. Is the Selling Over?